451
Views
7
CrossRef citations to date
0
Altmetric
Review

Heterogeneity in myasthenia gravis: considerations for disease management

, , &
Pages 761-771 | Received 31 Mar 2021, Accepted 26 May 2021, Published online: 22 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Marinos C Dalakas. (2022) Role of complement, anti-complement therapeutics, and other targeted immunotherapies in myasthenia gravis. Expert Review of Clinical Immunology 18:7, pages 691-701.
Read now

Articles from other publishers (6)

Huseyin Nezih Ozdemir, Hatice Karasoy, Ayse Nur Yuceyar & Ozgul Ekmekci. (2023) Effects of comorbid diseases on clinical outcomes in patients with myasthenia gravis. Neurological Sciences 44:8, pages 2923-2931.
Crossref
Gregorio Spagni, Matteo Gastaldi, Pietro Businaro, Zeineb Chemkhi, Cinzia Carrozza, Giovanni Mascagna, Silvia Falso, Silvia Scaranzin, Diego Franciotta, Amelia Evoli & Valentina Damato. (2022) Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis. Neurology - Neuroimmunology Neuroinflammation 10:1, pages e200038.
Crossref
Valentina Damato, Gregorio Spagni, Gabriele Monte, Mark Woodhall, Leslie Jacobson, Silvia Falso, Thomas Smith, Raffaele Iorio, Patrick Waters, Sarosh R Irani, Angela Vincent & Amelia Evoli. (2022) Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis. Journal of Neurology, Neurosurgery & Psychiatry 93:9, pages 995-1000.
Crossref
Antonio Farina, Silvia Falso, Sara Cornacchini, Gregorio Spagni, Gabriele Monte, Alice Mariottini, Luca Massacesi, Alessandro Barilaro, Amelia Evoli & Valentina Damato. (2022) Safety and tolerability of SARS‐Cov‐2 vaccination in patients with myasthenia gravis: A multicenter experience. European Journal of Neurology 29:8, pages 2505-2510.
Crossref
George K. Papadimas, Roser Pons & Johanna Palmio. (2022) Editorial: Current and Future Developments in the Therapeutic Management of Neuromuscular Diseases. Frontiers in Neurology 12.
Crossref
Yi Li, Shumei Yang, Xiaohua Dong, Zhibin Li, Yuyao Peng, Wanlin Jin, Di Chen, Ran Zhou, Fei Jiang, Chengkai Yan & Huan Yang. (2022) Factors affecting minimal manifestation status induction in myasthenia gravis. Therapeutic Advances in Neurological Disorders 15, pages 175628642210805.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.